AllPennyStocks.com Micro Cap Bid Up Following FDA Submission Announcement

Micro Cap Bid Up Following FDA Submission Announcement

Micro Cap Bid Up Following FDA Submission Announcement By: Tomas Ronolski - AllPennyStocks.com News

Tuesday, July 9, 2024

A medical company based out of Germany is already turning heads during Tuesday’s premarket hours after the company announced the submission of its application to the U.S. Food and Drug Administration (FDA) requesting Breakthrough Device Designation for its non-invasive Next Generation colorectal cancer (CRC) product.

Shares of Mainz Biomed N.V. (Nasdaq:MYNZ) are being massively bid up prior to the opening bell, with traders currently willing to buy shares of this micro cap at $0.53/share (+11.11% implied open for sellers) at the time of writing. This move will come just one session following a run this stock had, with shares closing yesterday at $0.477/share (+22.94%).

Mainz Biomed is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. It's main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results.


Copyright © 2024 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Junior Miner Duo Find Collective Success On Tuesday
Micro Cap Already Off To The Races At The Bell
Energy Shares Bid Up At Open Following Major Announcement
Most Popular


Back to Top